VRDN
Viridian Therapeutics Inc
18.30$
+0.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.8% | -2.9% | +27.8% | +2.7% | +63.0% | -8.8% | +2.5% | -17.0% | -49.8% | +112.5% | +104.7% | +3.4% | -14.8% | |
| – | – | – | -29.9% | -30.0% | +14.1% | +52.7% | +7.9% | -8.2% | +296.8% | +36.6% | +239.9% | -37.3% | +5.1% | |
| – | – | – | – | – | +291.1% | +45.4% | +6.6% | +1,859.5% | -71.0% | -10.3% | – | – | – | |
| – | – | – | +946.7% | +98.5% | -304.7% | – | -14.9% | +168.1% | -61.1% | +825.9% | -159.0% | – | +140.0% | |
| – | -95.5% | +5,477.7% | -53.8% | -97.6% | +8,100.0% | +80.9% | -81.1% | -50.0% | +704.8% | +135.8% | +12.7% | -43.1% | -3.1% | |
| – | – | -4,919.7% | -65.3% | -96.8% | – | -2,992.4% | – | -278.8% | +47.2% | +55.0% | -18.1% | +142.6% | -83.6% | |
| – | -60.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -52.3% | +602.9% | +143.0% | – | – | – | -99.9% | +216.9% | – | – | |
| – | – | – | – | – | – | -143.7% | +0.0% | +267.2% | – | -8.9% | +229.4% | -100.0% | – | |
| – | -78.3% | +487.6% | +71.8% | -102.0% | – | -20.1% | -99.8% | +144,630.0% | +23.7% | +157.2% | -30.0% | +102.8% | -6.8% | |
| – | – | +4,971.6% | +16.4% | -231.1% | – | -158.6% | – | – | -117.1% | – | -146.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.